Stockreport

Oculis to Participate at Upcoming April Investor Conferences

Oculis Holding AG  (OCS) 
PDF ZUG, Switzerland and BOSTON, April 04, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to s [Read more]